Table 2 Genotype Distribution and Allele Frequency of Included Studies

From: C2 rs547154 polymorphism and polypoidal choroidal vasculopathy susceptibility: a meta-analysis

 

PCV

Control

    
  

Genotype

  

Genotype

  

Adjusted Results (T vs G)

  

Author

(N)

TT/TG/GG

T/G

T (%)

(N)

TT/TG/GG

T/G

T (%)

HWE p Value

OR [95% CI]

p Value

Adjusted Factors

Lee et al14

72

0/5/67

5/139

3.47

93

0/9/84

9/177

4.84

0.624

NA

NA

NA

Kondo et al15

136

1/19/116

21/251

7.72

183

2/32/149

36/330

9.84

0.848

NA

NA

NA

Lima et al16

55

0/4/51

4/106

3.63

368

5/77/286

87/649

11.82

0.943

NA

NA

NA

Nakata et al17

581

2/57/522

61/1101

5.25

865

5/121/739

131/1599

7.57

0.984

0.54 [0.35–0.84]

0.006

Age, Sex

Tanaka et al18

376

1/40/335

42/710

5.59

274

4/41/229

49/499

8.94

0.179

0.48 [0.26–0.89]

0.018

Multiple factors

  1. †Age, Sex, Hypertension, DM, Smoking.
  2. Abbreviations: PCV: polypoidal choroidal vasculopathy; HWE: Hardy–Weinberg equilibrium; NA: not available; OR: odds ratio; CI: confidence interval.